Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last year: Report [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
The report looked at eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Merck, Novartis and Novo Nordisk — that manufacture the 10 drugs whose prices are currently being negotiated by the Centers for Medicare & Medicaid Services (CMS). Among these eight companies, four — J&J, Bristol Myers Squibb, Novartis and Novo Nordisk — spent more on combined shareholder payments than on research and development. Five of the companies — J&J, Amgen, AstraZeneca, Novartis and Novo Nordisk — spent more on administrative and marketing costs than developing drugs. Merck was the sole company in the report that spent more on research and development than it did on executive compensation, marketing, administration and shareholder payments. Most of the companies in the report, J&J, Bristol Myers Squibb, AstraZeneca, Novo Nordisk, Novartis and Merck, sued to block the government's Medicare negotiation program. Several federal judges having ruled in favor of u
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution [Yahoo! Finance]Yahoo! Finance
- J&J-backed startup Rapport files for US IPO [Yahoo! Finance]Yahoo! Finance
- Medtronic study of Affera Sphere-9 Catheter meets endpoints [Seeking Alpha]Seeking Alpha
- Dow closes above 40,000 for first time, notching new milestone [CBS News]CBS News
- Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/17/24 - Form 8-K
- 5/16/24 - Form 424B2
- 5/15/24 - Form 424B2
- JNJ's page on the SEC website